Peter Schmidt

Peter Schmidt has extensive experience in leadership and research roles within the fields of neuroscience and immunology. Currently serving as President and Chief Scientific Officer at Rho since April 2022, Peter Schmidt provides strategic and operational leadership related to NIH, HHS, and commercial clinical research. Alongside this position, Peter Schmidt is the Senior Vice President of Government Partnerships at NYU Grossman School of Medicine and an adjunct professor of neurology at Dartmouth College, where responsibilities include leading analytics for a clinical trial focused on COVID-19 vaccine hesitancy. Peter Schmidt has also acted as Senior Advisor for the Fresco Foundation, promoting neurological care between the US and Italy, and served as Vice Dean for Operations at The Brody School of Medicine at East Carolina University, overseeing efforts to train future physicians. Educationally, Peter Schmidt holds an SB in Engineering from Harvard University and a Ph.D. in Biomechanics from Cornell University.